US › Healthcare

Propanc Biopharma, Inc. Common Stock (PPCB)

US · Healthcare · Biotechnology

$1.02-2.86%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-6.4M

Profit YoY

+88.2%

EPS

$-0.39

EPS estimate

$0.00

Key statistics

Market cap

$2.3M

P/E

0.0

Forward P/E

0.0

P/B

0.23

Book value

$11.24

EPS (TTM)

$570.50

52-week high

$268.00

52-week low

$0.95

50-day MA

$1.59

200-day MA

$9.42

Beta

3.30

Analyst view

with an average price target of $1.52.

Shareholding

Insiders

45.13%

Institutions

0.81%

Largest institutional holders

Fund	Stake
UBS Group AG	0.32%
Marex Group PLC	0.12%
Sassicaia Capital Advisers LLC	0.03%
XTX Topco Ltd	0.02%
Morgan Stanley - Brokerage Accounts	0.00%
Two Sigma Investments LLC	0.00%
TWO SIGMA SECURITIES, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Propanc Biopharma, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.